Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function - Hardman, C; Chen, W; Luo, J; Batty, P; Chen, Y; Nahler, J; Wu, Y; Pavord, I; Erpenbeck, V; Sandham, D; Xue, L; Ogg, G (Elsevier, 2019)